TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ECVT

Ecovyst Inc

Basic Materials · Specialty Chemicals

10.60$ -2.2% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Stock Watch

Stock Watch will tell you what changes at Ecovyst Inc.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 7.80 $ to 15.00 $ · Last price: 10.60 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 1.2$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 110m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 90.6%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 1.1

Performance

Perf. 1M ?Price performance over the last month. -8.00%
Perf. 3M ?Price performance over the last 3 months. -4.30%
Perf. 6M ?Price performance over the last 6 months. 25.20%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 31.40%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -19.7%
Perf. 1Y ?Price performance over the last 12 months. 15.03%
Perf. 3Y ?Price performance over the last 3 years. 1.14%
Perf. 5Y ?Price performance over the last 5 years. -10.14%
Perf. Since Inception ?Price performance since the first available trading day (09/29/2017) — with a complete history, that is since the IPO. -13.19%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 10.60$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 11.10$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 11.70$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 52.8
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 36.8%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 32.8%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 12.9
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey.
P/B ?Price-to-book ratio: market value relative to book equity.
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 1.3
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 9.7
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. 14.1

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 21.3%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. 6.4%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. -7.1%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 3.2%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 3.7%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. 46.1%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity.
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. 4.85
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. very solid 8 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY).
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 2.70%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 3.52%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. 34.20%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 2
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 73
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 50
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. B (56 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Specialty Chemicals

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Ecovyst Inc ECVT 1.2 9.7 21.3 6.4 2.7 15.0
Linde plc LIN 212.0 30.6 17.5 48.4 28.5 3.0 -3.2
Sherwin-Williams Co SHW 77.7 31.5 19.5 49.0 14.2 2.1 -7.5
Ecolab Inc ECL 76.7 37.6 21.6 44.2 16.9 2.2 3.5
Air Products and Chemicals Inc APD 64.1 30.2 48.8 32.1 23.6 -0.5 1.1
PPG Industries Inc PPG 23.5 15.3 10.4 41.2 13.7 0.2 -0.6
International Flavors & Fragrances Inc. IFF 21.7 26.8 59.0 36.6 10.1 -5.2 37.3
LyondellBasell Industries NV LYB 21.1 16.7 12.9 3.5 -25.2 27.6
Sociedad Quimica y Minera de Chile SA SQM 20.5 25.3 8.6 42.2 41.1 0.9 60.5
Median of companies shown 23.5 30.2 17.5 41.2 14.2 0.9 3.5

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 1,064 $M 2016 · Operating income: 84 $M 2016 · Net income: -80 $M 2017 · Revenue: 1,472 $M 2017 · Operating income: 168 $M 2017 · Net income: 58 $M 2018 · Revenue: 1,608 $M 2018 · Operating income: 184 $M 2018 · Net income: 58 $M 2019 · Revenue: 533 $M 2019 · Operating income: 66 $M 2019 · Net income: 80 $M 2020 · Revenue: 496 $M 2020 · Operating income: 52 $M 2020 · Net income: -279 $M 2021 · Revenue: 611 $M 2021 · Operating income: 55 $M 2021 · Net income: -140 $M 2022 · Revenue: 820 $M 2022 · Operating income: 104 $M 2022 · Net income: 74 $M 2023 · Revenue: 691 $M 2023 · Operating income: 97 $M 2023 · Net income: 71 $M 2024 · Revenue: 704 $M 2024 · Operating income: 98 $M 2024 · Net income: -7 $M 2025 · Revenue: 724 $M 2025 · Operating income: 78 $M 2025 · Net income: -71 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 1,064 84 -80 -1.02 120 1,023 4,260
2017 1,472 168 58 0.52 116 1,628 4,416
2018 1,608 184 58 0.43 249 1,660 4,327
2019 533 66 80 0.59 268 1,779 4,322
2020 496 52 -279 -2.04 224 1,277 3,198
2021 611 55 -140 -1.02 130 741 1,931
2022 820 104 74 0.55 187 707 1,885
2023 691 97 71 0.60 138 705 1,838
2024 704 98 -7 -0.06 150 700 1,802
2025 724 78 -71 -0.61 140 604 1,261

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 148.9 $M Q4 2025: Q1 · 143.1 $M Q1 2025: Q2 · 176.1 $M Q2 2025: Q3 · 204.9 $M Q3 2025: Q4 · 199.4 $M Q4 2026: Q1 · 215.0 $M Q1 2026: Q2 · 250.0 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.26 -202.20 149 123.90 -20.40 44 26
2025: Q1 -0.03 -395.10 143 -10.90 -2.50 10 -14
2025: Q2 0.05 -27.20 176 14.40 3.40 33 8
2025: Q3 -0.70 -672.20 205 14.40 -38.70 55 53
2025: Q4 0.05 199 33.90 2.90 42 23
2026: Q1 0.04 215 50.20 2.00 17 3
2026: Q2 0.07 40.00 250 42.00 3.20 34 4

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 3 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

Breakout & Setup

Momentum & Trend

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Strong Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 6
Price Target (average) 15.17$
Distance to price 43.1% The price target sits 43.1% above the current price.

Distribution of Recommendations

Strong Buy 4
Buy 2
Hold 0
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 0.69 0.67 – 0.70 1,027 77.3% 6
12/31/2027 0.88 0.77 – 0.97 1,069 26.7% 6

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.

Today’s market value implies roughly 4.7% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).

What is priced in?
Free cash flow (last twelve months) $72.2M
Market cap $1.16B
Free cash flow in year ten $114.7M
Terminal value as a share of market value 52.0%

For comparison: over the past five years free cash flow shrank by 16.5% per year.

It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Uses AI

Geprüft am 10.07.2026 gegen den Geschäftsbericht (10-K) 2025 (eingereicht 27.02.2026) und die vier jüngsten Quartalsberichte (10-Q). Ecovyst erzielt keine KI-Umsätze — das Kerngeschäft ist Schwefelsäure-Recycling für Raffinerien. Der Geschäftsbericht enthält aber einen ausdrücklichen, über bloße Cybersecurity-Floskeln hinausgehenden Beleg für operativen KI-Einsatz: Das Unternehmen erklärt in den Risk Factors (Item 1A) des 10-K 2025, es habe begonnen, KI und andere neue Technologien in verschiedenen Bereichen seiner Abläufe einzusetzen (Forschung, Fertigung, Kommerzialisierung) und pruefe weitere Anwendungsfaelle. Damit ist ein operativer KI-Einsatz belegt, ohne dass KI eine eigene Umsatzquelle waere — nach dem Kriterienkatalog (Rang 3) lautet die Einstufung 'nutzt' (analog zur Argan/AGX-Einstufung). Das Endmarkt-Narrativ rund um Raffinerien/Alkylat hat keinen KI-Bezug und begruendet fuer sich kein 'verkauft'.

View the full file — quotes, sources, reviewed filings
„We have begun to deploy AI and other emerging technologies in various facets of our operations, and we continue to explore further use cases."

Wir haben begonnen, KI und andere neue Technologien in verschiedenen Bereichen unserer Abläufe einzusetzen, und wir prüfen weiterhin zusätzliche Anwendungsfälle.

10-K · 2026-02-27 · View SEC filing

„The rapid advancement of these technologies presents opportunities for us in research, manufacturing, commercialization, and other business endeavors, but also entails risks, including that AI-generated content, analyses, or recommendations we utilize could be deficient."

Der rasche Fortschritt dieser Technologien eröffnet uns Chancen in Forschung, Fertigung, Kommerzialisierung und anderen Geschäftsfeldern, birgt aber auch Risiken — etwa, dass von uns genutzte KI-generierte Inhalte, Analysen oder Empfehlungen mangelhaft sein könnten.

10-K · 2026-02-27 · View SEC filing

Filings Reviewed: 10-Q 2026-05-05 · 10-Q 2025-11-05 · 10-Q 2025-08-07 · 10-Q 2025-05-02 · 10-K 2026-02-27 · 10-K 2025-02-28

Rated on July 10, 2026 · How the Rating Is Built

Earnings calls

What the Earnings Calls Reveal

Between the closing quarter of 2023 and the opening quarter of 2026, Ecovyst reshaped itself from a dual business of sulfuric acid services and specialty catalysts into a pure sulfur specialist. Across the first two years of that stretch, several stated dates were pushed back: the 2024 full-year outlook, the leverage target and the start of recycling revenue. Management did, however, name and explain each of those shifts on the call itself; none was dropped quietly. Since the call for 2025-Q1 the picture is markedly cleaner, with quarterly targets met or beaten every time. The weak spots stem almost entirely from the catalyst business that has since been sold.

Red flags promises repeatedly deferred 10 calls reviewed, 2023-Q4 through 2026-Q1 · As of August 3, 2026

2024 outlook cut in summer

On the call for 2023-Q4, management guided full-year 2024 adjusted EBITDA to 255 to 275 million dollars, plus free cash flow of 85 to 105 million. On the call for 2024-Q1 that range was explicitly reaffirmed without change. Just one quarter later, on the call for 2024-Q2, management cut it to 230 to 245 million, while the expected sales contribution of the catalyst joint venture was trimmed by 30 million. The range then held: it was reaffirmed on the call for 2024-Q3, and the call for 2024-Q4 reported an actual figure of 238 million, roughly ten percent below the midpoint of the original range but inside the revised one. So there was a single cut, not a series. Free cash flow, guided at the same time, came in above 85 million and thus inside the original range. The stated reason was the collapse in renewable diesel incentive credits from above 1.50 to below 0.50 dollars. An analyst objected on the same call that the credits had been falling for a while; management explained the lag by noting that it supplies technology licensors and that the effect only feeds through via deferred investment decisions and extended catalyst life.

Leverage ratio flat in 2024

On the call for 2023-Q4 the CFO announced that 2024 would bring nearly half a turn of deleveraging, moving substantially toward the stated target of below 2.5. That statement carried two caveats spelled out in the same sentence: the expected cash generation, and the assumption that no cash would be used for other capital allocation priorities. In fact net leverage stood at 3.0 at the end of 2023, rose to 3.3 per the call for 2024-Q2, and was back at 3.0 at the end of 2024. Net debt itself did fall: per the calls, cash rose from 88 to 146 million dollars with a single unchanged debt tranche. Only the ratio stayed put, because earnings dropped from 260 to 238 million. On the call for 2024-Q3 an analyst asked directly whether the target would be met by the end of 2025; the answer fell back on the generic rule of thumb of half a turn per year, with no commitment. On the call for 2025-Q1 the target was openly and explicitly deferred in favor of share buybacks, and the call for 2025-Q2 showed the figure rising to 3.5, which the same call attributed to the Waggaman acquisition and the buybacks; excluding both it would have been 3.2. The company only moved below the target through the sale of the catalyst business, reaching 1.2 per the call for 2025-Q4.

Market forecast doubled between calls

One figure used to justify the outlook was swapped between two adjacent calls without any explanation. On the call for 2023-Q4 management said North American capacity for renewable diesel and sustainable aviation fuel would grow by about 33 percent in 2024 and European capacity by 43 percent. Just two months later, on the call for 2024-Q1, the same year was described as over 70 percent in North America and 26 percent in Europe, with no comment, even though both sets of numbers served as evidence for the demand outlook. To be fair, these are third-party market projections rather than company targets, and the revision ran in both directions. The Euro 7 emissions standard, by contrast, does not qualify as a contradiction: the call for 2023-Q4 said it had been due for heavy-duty vehicles in 2027 and was delayed by two years, while the call for 2024-Q2 said it had been due in 2025 and was delayed for heavy-duty vehicles by four years. Both statements land on the same year, 2029, and the four-year deferral was then repeated unchanged on the calls for 2024-Q3 and 2024-Q4.

Recycling sales pushed twice and never delivered

On the call for 2023-Q4 management pointed to commercial sales of plastics recycling catalysts in early 2025. On the call for 2024-Q2 this became a ramp across 2025 and 2026, and on the call for 2024-Q4 a start between late 2025 and early 2026. On the call for 2025-Q2 the language was still about customers testing pilot samples. No commercial revenue was reported on any call up to the sale of the segment, and the business passed to the buyer with that sale. The promised recovery in sulfuric acid for nylon precursors, also flagged on the call for 2023-Q4, is a different case: what was promised there was never a boom, only a gain over a weak prior year, and per the calls management reported exactly that gain for both 2024 and 2025, albeit from a low level. For 2026 the call for 2025-Q4 expects a broadly flat level.

Expansion project went to the buyer

From 2023-Q4 through 2024-Q4 the 50 percent expansion of catalyst production in Kansas City was the central growth argument, explicitly described as backed by firm customer commitments and aimed at a ramp in 2026 and 2027, with capital spending raised accordingly. The later sale was not, however, a pivot without warning: the strategic review of the entire segment was announced in December 2024 and repeated on the calls for 2024-Q4, 2025-Q1 and 2025-Q2, each time with the explicit note that a full spectrum of options was on the table. What did slip was the timing: the review was to be completed by mid 2025, and as late as the call for 2025-Q2 in August management said it remained on that timeline. The outcome only came on the call for 2025-Q3 in November: sale of the entire segment for 556 million dollars, moving the expansion project and the customer commitments to the buyer. For balance, the other side belongs here too: since the call for 2025-Q1 every quarterly target has been met or beaten, the sale closed earlier than planned per the call for 2025-Q4, and most recently the call for 2026-Q1 showed adjusted EBITDA of 40 million dollars above the company's own range.

Management promises

  • 2023-Q4 — Adjusted EBITDA for 2024 of 255 to 275 million dollars. Cut once to 230 to 245 million on the call for 2024-Q2; the call for 2024-Q4 reported 238 million. The free cash flow guided at the same time, 85 to 105 million, was met at above 85 million. broken
  • 2023-Q4 — Deleveraging by nearly half a turn during 2024 and substantial progress toward the below 2.5 target. The pledge came with the explicit caveat that no cash would be used for other priorities. Net leverage stood at 3.0 at both the end of 2023 and the end of 2024, and at 3.3 in between per the call for 2024-Q2. Net debt did fall (cash from 88 to 146 million with an unchanged debt tranche), but the ratio held because earnings dropped. The target was openly deferred on the call for 2025-Q1. broken
  • 2023-Q4 — Commercial sales of plastics recycling catalysts starting in early 2025. Date pushed twice, on the calls for 2024-Q2 and 2024-Q4; the call for 2025-Q2 still referred to pilot samples. No commercial revenue reported up to the segment sale. broken
  • 2024-Q2 — The weakness in renewable diesel will last 12 to 18 months, followed by recovery. The identical 12 to 18 month window was repeated unchanged on the calls for 2024-Q3 and 2024-Q4, effectively resetting the clock twice. For 2025 only flat to slightly up was expected on the calls for 2025-Q1 and 2025-Q2. broken
  • 2024-Q4 — Completion of the strategic review of the catalyst segment by mid 2025. The call for 2025-Q2 in August 2025 still claimed the timeline held; the outcome was only announced on the call for 2025-Q3 in November. broken
  • 2025-Q3 — Use of 450 to 500 million dollars of sale proceeds to repay the term loan, bringing net leverage below 1.5. Confirmed on the call for 2025-Q4: 465 million repaid, net leverage of 1.2 at year end. kept
  • 2025-Q4 — Share repurchases of 25 to 40 million dollars during 2026. The call for 2026-Q1 already reported 36 million repurchased, nearly exhausting the range in the first quarter. Final outcome still pending. open

Based on public earnings call transcripts. Reviewed: 10 transcripts 2023-Q4 through 2026-Q1.

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

6 of 10 Solid growth
  • Revenue grows by more than 15% a year over three years -4.1%
  • More than 10% revenue growth is expected for the coming year 3.5%
  • Share count grows by less than 3% a year -5.0%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 12.4%
  • Gross margin at 40% or higher and without meaningful erosion 21.9%
  • Goodwill from acquisitions does not grow faster than revenue 25.9%
  • Net debt below twice EBITDA 1.7 x EBITDA
  • Operating cash flow covers the profits of the last three years 434 m
  • Return on capital at 15% or higher, or up versus two years ago 6.9%
  • Insiders hold at least 10% or are net buyers 1.9%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

5/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% -4.2%
  • Exp. sales growth 3Y > 5% 21.5%
  • EBIT growth 10Y > 5% -0.8%
  • Exp. EBIT growth 3Y > 5% 21.5%
  • Net debt < 4x EBIT 3.0x
  • EBIT positive, 10Y straight 10
  • Max. EBIT decline < 50% 71.9%
  • Return on equity > 15% -32.7%
  • ROCE > 15% 6.9%
  • Expected return > 10% 28.9%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Sep 10, 2026 Humble Patti A. Director Buy 24,875 10.05 249,994
Aug 24, 2026 Bergman Laurie See Remarks Other 43,353 0.00

View all insider transactions →

The company

About the Company

Ecovyst Inc. bietet frische und regenerierte Schwefelsäureprodukte und -dienstleistungen in den USA und international an.

Employees
617
Headquarters
Wayne, PA
Address
600 Lee Road, 19087 Wayne, United States
Phone
484 617 1200
IPO Date
08/03/2021
ISIN
US27923Q1094

Management

Management
Name Title Birth Year
Kurt J. Bitting CEO & Director 1976
Joseph S. Koscinski Chief Administrative Officer, VP, Secretary & General Counsel 1966
Michael P. Feehan Vice President 1976
Laurie A. Bergman Chief Financial Officer 1978
Paul B. Hoelzer Vice President of Operations 1964
H. Gene Shiels Director of Investor Relations
Wendy Graham Vice President of Marketing & Commercial Strategy
Kara L. Thornton VP & Chief Human Resources Officer 1976
Colleen Grace Donofrio Vice President of Environment & Sustainability 1959
Mark S. Baunchalk Senior Vice President of Business Development & Strategy 1958

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 08/24/2026 Ecovyst Inc. (ECVT): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
  • 08/05/2026 Ecovyst Inc. (ECVT): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?